Session IV - Tibia


Moderator: William T. Obremskey, MD, MPH & Kyle J. Jeray, MD


Fri., 10/19/07 Tibia, Paper #21, 10:30 am OTA-2007

A Randomized Trial of Reamed versus Non-Reamed Intramedullary Nail Insertion on Rates of Reoperation in Patients with Fractures of the Tibia

Mohit Bhandari, MD (n);
McMaster University, Hamilton, Ontario, Canada


Fri., 10/19/07 Tibia, Paper #22, 10:36 am OTA-2007

Functional, General, and Disability Outcomes after Tibial Nailing: A Randomized Trial

Mohit Bhandari, MD1 (n); Paul Tornetta, III, MD2 (n);
1McMaster University, Hamilton, Ontario, Canada;
2Boston Medical Center, Boston, Massachusetts, USA


Fri., 10/19/07 Tibia, Paper #23, 10:48 am OTA-2007

Routine Use of Wound Vacuum-Assisted Closure Does Not Allow Coverage Delay for Open Tibia Fractures

Timothy Bhattacharyya, MD (e-Stryker); Priyesh Mehta, BA (n);
R. Malcolm Smith, MD (n); Bohdan Pomahac, MD (n);
Partners Orthopaedic Trauma Service, Massachusetts General Hospital and
Brigham and Women’s Hospital, Boston, Massachusetts, USA


Fri., 10/19/07 Tibia, Paper #24, 10:54 am OTA-2007

Lateral Locking Plates for the Treatment of Bicondylar Tibial Plateau Fractures:  A Treatment Protocol, Indications, and Results

J. Tracy Watson, MD (n); Matthew Phillips, MD (n);
Dave Karges, MD (e-Zimmer); James Jackman, MD (n);
Division of Orthopaedic Traumatology, Department of Orthopedic Surgery,
St. Louis University School of Medicine, St. Louis, Missouri, USA


If noted, the author indicates something of value received. The codes are identified as a-research or institutional support; b-miscellaneous funding; c-royalties; d-stock options; e-consultant or employee; n-no conflicts disclosed, and *disclosure not available at time of printing.

• The FDA has not cleared this drug and/or medical device for the use described in this presentation   (i.e., the drug or medical device is being discussed for an “off label” use).  ◆FDA information not available at time of printing.